28 related articles for article (PubMed ID: 15339087)
1. Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Zinzani PL; Salles G; Moskowitz AJ; Santoro A; Mehta A; Barr PM; Mehta-Shah N; Collins GP; Ansell SM; Brody JD; Domingo-Domenech E; Johnson NA; Cunningham D; Ferrari S; Lisano J; Krajewski J; Wen R; Akyol A; Crowe R; Savage KJ
Blood Adv; 2024 May; 8(10):2400-2404. PubMed ID: 38531062
[No Abstract] [Full Text] [Related]
2. [Analytical study of 13 cases of cutaneous lymphoma].
Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
[No Abstract] [Full Text] [Related]
3. Granulomatous slack skin with extracutaneous involvement and a good response to bortezomib-based chemotherapy.
Zeng YP; Li J; Zhong DR; Jin HZ; Sun QN; Fang K; Li J
Eur J Dermatol; 2013; 23(5):708-10. PubMed ID: 24211790
[No Abstract] [Full Text] [Related]
4. A case of adult T-cell leukemia/lymphoma in the Midwest.
Wu PA; Lee BA; Anadkat MJ
J Am Acad Dermatol; 2011 Aug; 65(2):432-434. PubMed ID: 21763572
[No Abstract] [Full Text] [Related]
5. Localized cutaneous T cell lymphoma presenting as disfiguring facial lesions.
Kaliyadan F; Jayasree MG; Unni M; Neeraj S
Dermatol Online J; 2009 Nov; 15(11):14. PubMed ID: 19951650
[No Abstract] [Full Text] [Related]
6. Angioimmunoblastic T-cell lymphoma with cutaneous involvement.
Mahendran R; Grant JW; Hoggarth CE; Burrows NP
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):589-90. PubMed ID: 11843225
[No Abstract] [Full Text] [Related]
7. Nodal peripheral T-cell lymphoma with secondary granulomatous cutaneous involvement.
Marzano AV; Vanotti M; Boneschi V; Gianelli U; Alessi E
Acta Derm Venereol; 2004; 84(4):325-7. PubMed ID: 15339087
[No Abstract] [Full Text] [Related]
8. T-zone lymphoma with cutaneous involvement: a case report and review of the literature.
Kazakov DV; Kempf W; Michaelis S; Schmid U; Cogliatti S; Dummer R; Burg G
Br J Dermatol; 2002 Jun; 146(6):1096-100. PubMed ID: 12072087
[TBL] [Abstract][Full Text] [Related]
9. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and staging of cutaneous T-cell lymphoma.
Foss FM; Sausville EA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1011-9. PubMed ID: 8522481
[TBL] [Abstract][Full Text] [Related]
11. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma.
Zhang C; Duvic M
Dermatol Ther; 2003; 16(4):322-30. PubMed ID: 14686975
[TBL] [Abstract][Full Text] [Related]
12. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
James E; Sokhn JG; Gibson JF; Carlson K; Subtil A; Girardi M; Wilson LD; Foss F
Leuk Lymphoma; 2015 Apr; 56(4):951-7. PubMed ID: 24996443
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
